Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel regulators of Fgf23 expression and mineralization in Hyp bone.

Molecular endocrinology (Baltimore, Md.) - 1 Sept 2009

Liu Shiguang, Tang Wen, Fang Jianwen, Ren Jinyu, Li Hua, Xiao Zhousheng, Quarles L D

Abstract excerpt

We used gene array analysis of cortical bone to identify Phex-dependent gene transcripts associated with abnormal Fgf23 production and mineralization in Hyp mice. We found evidence that elevation of Fgf23 expression in osteocytes is associated with increments in Fgf1, Fgf7, and Egr2 and decrement...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta Catenin
Share to Familial Hypophosphatemic Rickets
Share to Fibroblast Growth Factor-23

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fibroblast Growth Factors

Share to Oligonucleotide Array Sequence Analysis

Share to Osteoblasts

Share to Osteocytes

Share to PHEX Phosphate Regulating Neutral Endopeptidase

Source

Open in PubMed Open full text

Identifiers

PMID: 19556340
DOI: 10.1210/me.2009-0085
PMCID: PMC2737552

Genes

FGF23

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19556340-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel regulators of Fgf23 expression and mineralization in Hyp bone.PMID 19556340Read ↗

Hexa-D-arginine treatment increases 7B2•PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype.Semantic proximity Read ↗

FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.Semantic proximity Read ↗

Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.Semantic proximity Read ↗

X-Linked Hypophosphatemia: A Review of Pathophysiology, Clinical Manifestations, Current Management, and Emerging Therapeutic StrategiesSemantic proximity Read ↗

Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.Semantic proximity Read ↗

Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice.Semantic proximity Read ↗

Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.Semantic proximity Read ↗

Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation.Semantic proximity Read ↗

Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.Semantic proximity Read ↗

Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype.Semantic proximity Read ↗

Mechanistic insights into mutations that cause diseases of phosphate dysregulation.Semantic proximity Read ↗

PTH, FGF-23, Klotho and Vitamin D as regulators of calcium and phosphorus: Genetics, epigenetics and beyondSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.